Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Vitreoretinal Diseases and Surgery
How do you approach treatment in patients with pachychoroid disease who show fluctuating subretinal fluid without visual decline?
Related Questions
How do you approach the use of tPA in patients undergoing PPV for endophthalmitis when dense fibrin or membranes are present preoperatively?
When should methotrexate injections be initiated for proliferative vitreoretinopathy?
How do you decide when to stop anti-VEGF injections for patients with exudative AMD?
How has using a chandelier for scleral buckling impacted your teaching or surgical outcomes?
In eyes with chronic DME despite frequent anti-VEGF, what is your threshold to add or switch to intravitreal steroid therapy?
How often do you monitor asymptomatic atrophic holes and lattice in pediatric patients?
What clinical or OCT-based parameters guide your decision to perform an ERM peel in patients with DME and concurrent ERM?
Does using a heads-up display for surgery improve ergonomics and surgical performance compared to a traditional microscope, or does the need to alternate between views reduce its long-term usability?
Would you recommend observation or laser retinopexy in a young myope with asymptomatic lattice degeneration with retinal holes within lattice in each eye?
How would you manage a patient who develops a 1 mm abscess at the internal os of the paracentesis tract following an AC tap after an Izervay injection with eye pain but no vitreous cell or retinal involvement?
